Topical Multiple Ascending Dose Study for PF-06423264

Summary

The current study is the first clinical trial proposed with PF-06423264. It is designed to evaluate the safety, tolerability, and pharmacokinetics (PK) following administration of multiple ascending doses of PF-06423264 to healthy adult subjects with or without oily skin.

Timeline

Start

2016-05-23

Primary completion

2017-05-23

Completion

2017-05-23

Outcome

Outcome not reported

Stopped (Enrollment): “Preliminary analysis of accrued data failed to indicate any meaningful pharmacodynamic response.”

Drugs

Indications

No indication recorded.